Candel Therapeutics Inc. (NASDAQ: CADL)
$7.18
+0.5550 ( +8.38% ) 458.3K
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Market Data
Open
$7.18
Previous close
$6.62
Volume
458.3K
Market cap
$211.57M
Day range
$6.47 - $7.30
52 week range
$0.66 - $14.30
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Oct 18, 2023 |
8-k | 8K-related | 14 | Sep 26, 2023 |
10-q | Quarterly Reports | 81 | Aug 10, 2023 |
8-k | 8K-related | 16 | Aug 10, 2023 |